Abstract
The deubiquitylase (DUB) USP37 is a component of the ubiquitin system and controls cell proliferation by regulating the stability of the cyclin-dependent kinase inhibitor 1B, (CDKN1B/p27Kip1). The expression of USP37 is downregulated in human medulloblastoma tumor specimens. In the current study, we show that USP37 prevents medulloblastoma growth in mouse orthotopic models, suggesting that it has tumor-suppressive properties in this neural cancer. Here, we also report on the mechanism underlying
loss in medulloblastoma. Previously, we observed that the expression of
is transcriptionally repressed by the
silencing transcription factor (REST), which requires chromatin remodeling factors for its activity. Genetic and pharmacologic approaches were employed to identify a specific role for G9a, a histone methyltransferase (HMT), in promoting methylation of histone H3 lysine-9 (H3K9) mono- and dimethylation, and surprisingly trimethylation, at the
promoter to repress its gene expression. G9a inhibition also blocked the tumorigenic potential of medulloblastoma cells
Using isogenic low- and high-REST medulloblastoma cells, we further showed a REST-dependent elevation in G9a activity, which further increased mono- and trimethylation of histone H3K9, accompanied by downregulation of
expression. Together, these findings reveal a role for REST-associated G9a and histone H3K9 methylation in the repression of
expression in medulloblastoma.
Reactivation of USP37 by G9a inhibition has the potential for therapeutic applications in REST-expressing medulloblastomas.
.